Altimmune, Inc.
ALTNasdaqCIK 1326190HealthcareFiscal year ends Dec 31
Reports and events: 367 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2708:16 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-118991 |
| 2026-09-2907:03 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001326190-26-000056 |
| 2026-08-1216:04 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001326190-26-000052 |
| 2026-08-1207:33 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001326190-26-000049 |
| 2026-07-2807:04 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001326190-26-000044 |
| 2026-06-1616:05 ET | 8-K | 8.01 Other events | 0001104659-26-074575 |
| 2026-05-1316:13 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001326190-26-000040 |
| 2026-05-1307:34 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001326190-26-000037 |
| 2026-04-2416:05 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-26-048552 |
| 2026-04-1617:07 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001326190-26-000027 |
| 2026-03-1707:05 ET | DEF 14A | Proxy statementPeriod 2026-04-16 | 0001104659-26-028953 |
| 2026-03-0607:56 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001326190-26-000018 |
| 2026-03-0507:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001326190-26-000013 |
| 2026-02-0316:05 ET | 8-K | 8.01 Other events | 0001326190-26-000008 |
| 2026-01-2817:26 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001326190-26-000006 |
| 2025-12-1906:30 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-122724 |
| 2025-12-0108:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-117144 |
| 2025-11-0616:30 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001326190-25-000067 |
| 2025-11-0616:10 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001326190-25-000064 |
| 2025-11-0607:04 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001326190-25-000055 |
| 2025-10-0316:02 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001326190-25-000053 |
| 2025-09-2516:07 ET | 8-K | 5.07 Shareholder vote results | 0001326190-25-000050 |
| 2025-08-1516:11 ET | DEF 14A | Proxy statementPeriod 2025-09-25 | 0001326190-25-000046 |
| 2025-08-1210:15 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001326190-25-000040 |
| 2025-08-1207:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-011145 |
| 2025-06-2607:30 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001326190-25-000037 |
| 2025-05-1316:55 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001326190-25-000034 |
| 2025-05-1307:04 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001326190-25-000031 |
| 2025-03-1316:03 ET | 8-K | 8.01 Other events | 0001326190-25-000024 |
| 2025-02-2716:30 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001326190-25-000015 |
| 2025-02-2707:05 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001326190-25-000011 |
| 2025-02-2507:32 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001326190-25-000003 |
| 2024-12-1117:19 ET | 8-K | 8.01 Other events | 0001326190-24-000053 |
| 2024-11-1216:06 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001326190-24-000050 |
| 2024-11-1207:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001326190-24-000047 |
| 2024-11-1206:46 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001326190-24-000046 |
| 2024-09-2616:45 ET | 8-K | 5.07 Shareholder vote results | 0001326190-24-000042 |
| 2024-08-1516:08 ET | DEF 14A | Proxy statementPeriod 2024-09-26 | 0001326190-24-000038 |
| 2024-08-1516:03 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001326190-24-000036 |
| 2024-08-0816:07 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001326190-24-000030 |
| 2024-08-0807:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001326190-24-000027 |
| 2024-06-2607:33 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001326190-24-000022 |
| 2024-05-0916:05 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001326190-24-000019 |
| 2024-05-0907:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001326190-24-000016 |
| 2024-03-2716:03 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001326190-24-000010 |
| 2024-03-2707:04 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001326190-24-000006 |
| 2023-11-3016:28 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001326190-23-000050 |
| 2023-11-0716:08 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001326190-23-000047 |
| 2023-11-0707:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001326190-23-000044 |
| 2023-09-2816:55 ET | 8-K | 5.07 Shareholder vote results | 0001326190-23-000040 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 07:04 ET. Listed shows no prices and gives no investment advice.